Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Galprofen 100mg/5ml oral suspension
1001010J0CCADBH
|
Galprofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Galprofen 200mg tablets
1001010J0CCAAAD
|
Galprofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Galprofen Cold and Flu 200mg tablets
1001010J0CCABAD
|
Galprofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Galprofen Long Lasting 200mg capsules
1001010J0CCACBA
|
Galprofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Galprofen Long Lasting 300mg capsules
1001010J0CCAFAB
|
Galprofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Galprofen Migraine Relief 200mg capsules
1001010J0CCAEAA
|
Galprofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.